Frazier Life Sciences

Frazier Life Sciences is a leading healthcare investment firm focused on supporting innovative therapeutics companies from early-stage creation to public market scale. Its investments have contributed to over 50 FDA-approved therapeutics since 2010. The firm manages more than $3.9 billion across venture and public funds and has backed over 200 healthcare/life sciences companies globally. Recent notable investments include Chinook Therapeutics (acquired by Novartis), Sierra Oncology (acquired by GSK), Alpine Immune Sciences (acquired by Vertex), among others. The firm’s approach includes both private venture funding and significant positions in small/mid-cap public biotech firms.